◀ Back to NFKB1
CISH — NFKB1
Text-mined interactions from Literome
Park et al., DNA Cell Biol 2003
:
Regulatory
effect of
SOCS on
NF-kappaB activity in murine monocytes/macrophages
Frobøse et al., Mol Endocrinol 2006
:
Suppressor of cytokine signaling (SOCS)-3 was shown to
inhibit IL-1 induced transcription and activation of
NFkappaB and the MAPKs JNK and p38, but the mechanism is unknown
Dai et al., J Invest Dermatol 2006
:
However,
SOCS1 did not
affect NF-kappaB signaling
Kaneko et al., J Immunol 2008
:
In addition, activation of
NF-kappaB and lipid peroxidation were
induced by
cis-UCA and SSR, but not trans-UCA, suggesting possible upstream events of the gene expression changes
Hu et al., J Immunol 2009
(Cryptosporidiosis...) :
Moreover, gain-of-function ( by overexpression of CIS ) and loss-of-function ( by siRNA interference ) studies revealed that
CIS could enhance IkappaBalpha degradation and
regulate NF-kappaB activation in cholangiocytes in response to LPS stimulation or C. parvum infection
Hommelberg et al., Lipids 2010
(Insulin Resistance) :
Of all tested unsaturated FAs, only elaidic acid ( 3-fold ),
cis9,trans11-CLA ( 3-fold ) and trans10,cis12-CLA ( 13-fold )
increased NF-kappaB transactivation in myotubes
Strebovsky et al., Frontiers in bioscience (Landmark edition) 2012
:
A model is presented that integrates the current, partly conflicting, data on the
role of
SOCS proteins in innate immunity 's
NFkappaB signaling